Topic: Government Payers

  • Could High Drug Prices Be Bad for Innovation?

  • Reforming the Payment System for Medical Oncology

  • Comparative Effectiveness Research in Medicare Coverage and Reimbursement

  • Limits on Medicare’s Ability to Control Rising Spending on Cancer Drugs